Comment on

• Key cost drivers of pharmaceutical clinical trials in the United States.

  Sertkaya A, Wong HH, Jessup A, Beleche T. Sertkaya A, et al. Clin Trials. 2016 Apr;13(2):117-26. doi: 10.1177/1740774515625964. Epub 2016 Feb 8. Clin Trials. 2016. PMID: 26908540
• Selling Stem Cells in the USA: Assessing the Direct-to-Consumer Industry.

  Turner L, Knoepfler P. Turner L, et al. Cell Stem Cell. 2016 Aug 4;19(2):154-157. doi: 10.1016/j.stem.2016.06.007. Epub 2016 Jun 30. Cell Stem Cell. 2016. PMID: 27374789
• Boom in unproven cell therapies intensifies regulatory debate.

  Ledford H. Ledford H. Nature. 2016 Sep 8;537(7619):148. doi: 10.1038/537148a. Nature. 2016. PMID: 27604928 No abstract available.